We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (RA) (MDX1100-04)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01017367
Recruitment Status : Completed
First Posted : November 20, 2009
Last Update Posted : April 23, 2010
Information provided by:
Bristol-Myers Squibb